Montene 4 mg (Dispersible Tablet)
Medicine Details
| Category | Details |
|---|---|
| Generic | Montelukast sodium |
| Company | Square pharmaceuticals plc |
| Also available as |
Title
Montene 4 mg Tablet
Categories
- Asthma Medication
- Allergic Rhinitis Medication
- Leukotriene Receptor Antagonist
Description
Montene 4 mg Tablet is indicated for prophylaxis and chronic treatment of asthma, acute prevention of Exercise-Induced Bronchoconstriction (EIB), and relief of symptoms of Allergic Rhinitis (AR). It is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT1). The dosage varies for adults, adolescents, and pediatric patients based on age, with precausions and overdosage effects outlined. Montene 4 mg Tablet has been shown to have common, uncommon, and rare side effects. It is contraindicated in patients who are hypersensitive to any component of the product.
Dimensions
N/A
Color Options
N/A
Functions
- Prophylaxis and chronic treatment of asthma
- Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
- Relief of symptoms of Allergic Rhinitis (AR)
Materials
N/A
Technical Specifications
- Molecular Formula: C35H36ClNO3S
- Chemical Structure: Refer to provided image of Montelukast Sodium
Design Elements
N/A
Usability Features
- Dosage & Administration Guidelines for Adults, Adolescents, and Pediatric Patients
- Interaction with other Therapies
- Pregnancy & Lactation Precautions
- Precautions & Warnings for Use
Indications
- Prophylaxis and chronic treatment of asthma
- Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
- Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis
Pharmacology
Leukotriene receptor antagonists
Dosage & Administration
- Varied dosage for Adults, Adolescents (15 years of age and older), and Pediatric Patients (2 years to 14 years of age)
- Use in Pediatric patients (6 months to 14 years of age)
- Hepatic and Renal Insufficiency guidelines
- Elderly use
Interaction
- No clinically important effects on the pharmacokinetics of specified drugs observed
- Recommendations for concomitant use with common prescribed drugs
- Interaction with hepatic metabolism inducers
Contraindications
- Hypersensitivity to any component of the product
Side Effects
- Common
- Uncommon
- Rare
Pregnancy & Lactation
Crosses the placenta in rats and rabbits, cautious use during pregnancy and lactation
Precautions & Warnings
- Not for reversal of bronchospasm in acute asthma attacks
- Use during acute exacerbations of asthma
- Caution in patients with known aspirin sensitivity
Overdose Effects
Overdose reports consistent with safety profile of the product
Therapeutic Class
Leukotriene receptor antagonists
Storage Conditions
Cool & dry place below 30°C, protect from light & moisture
Chemical Structure
- Molecular Formula: C35H36ClNO3S
- Chemical Structure Image: Refer to provided image of Montelukast Sodium
Commonly Asked Questions
- What is Montene 4 mg DT?: Selective and orally active leukotriene receptor antagonist
- What is Montene 4 mg DT used for?: Treatment of asthma or allergic rhinitis, blocking leukotrienes to keep airways open
- How soon can the effect be observed?: 1-3 hours after administration
- How long does the effect last?: Average duration of 24 hours
- Should it be taken empty stomach?: May be taken with or without food as prescribed
- What if a dose is missed?: Take it as soon as possible, do not double up on doses
- Are there any pregnancy warnings?: Avoid use in pregnant women unless clearly needed
- General Instructions:
- Take Montene 4 mg DT: Exactly as prescribed by the doctor
- Do not change dose without doctor's advice: 1
- Not a fast-acting rescue medicine: Seek medical attention for worsening breathing problems
- Avoid triggering asthma attack: 1
- Consult doctor if pregnant or breastfeeding: 1